Further supporting these findings, lung cancer cells incubated with conditioned media from BMAL1-deficient CAMs showed augmented NLRP3 inflammasome activation, driving cancer cell proliferation, consisting to the effects that observed in breast cancer with BMAL1 knockdown [43]. This evidence concerns the gene NLRP3 and lung cancer.